Clinical Trials Browser

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT05139706 2026-02-03

MIRAE

Recruiting

1,000 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Autoimmune Diseases, Immune System Diseases, Inflammation, Neoplasms

NCT01287000 2026-01-28

Gulf Long-Term Follow-Up Study

Active not recruiting

32,658 enrolled

Psychological Well-Being, Cardiovascular Diseases, Hematologic Diseases, Immune System Diseases, Neoplasms, Respiratory Aspiration

NCT04830046 2025-11-26

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Completed

146 enrolled

LymphoidPlasma cell

COVID-19, Immune System Diseases, Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT04656873 2025-09-04

IOG

Active not recruiting

32 enrolled

Autoimmune Diseases, Immune System Diseases, Neoplasms

NCT03207854 2025-07-11

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Recruiting

500 enrolled

Other hematologic neoplasm

Hematologic Diseases, Immune System Diseases, Neoplasms, Hematologic Neoplasms

NCT05969821 2025-06-12

CHIS

Not yet recruiting

1,000 enrolled

LymphoidMyeloidOther hematologic neoplasm

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT04658303 2025-05-08

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

Recruiting

20 enrolled

Dermatologic

Immune System Diseases, Melanoma

Clinical Trials

LEO

MIRAE

Gulf Long-Term Follow-Up Study

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

IOG

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

CHIS

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma